Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Cocrystal Pharma Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
VC
Vanguard Capital Management LLC
|
358.2K | 1.86% | +118.3K (+49.3%) | 2022 | 0.0% | |
|
Shares held by quarter
Peak holding358.2K (Q2'26)
Change over 8 quarters+358.2K
Share of the company1.860%
|
||||||
|
RT
Renaissance Technologies LLC
|
179.6K | 0.93% | +55.7K (+44.9%) | 2022 | 0.0% | |
|
Shares held by quarter
Peak holding179.6K (Q2'26)
Change over 8 quarters+49.6K
Share of the company0.930%
|
||||||
28 more super investors behind a free account
See every manager holding Cocrystal Pharma Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$197K | 187.3K | 0.97% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$180K | 171.0K | 0.89% | 0.00% | June 30, 2026 |
4 more funds behind a free account
See every fund holding Cocrystal Pharma Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
OH
Opko Health, Inc.
5%+ holder
13D · 29.6%
|
5.7M | 29.55% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
FP
Frost Phillip MD Et Al
5%+ holder
13D · 13.9%
|
2.8M | 14.46% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
5 more holders behind a free account
See every insider and 5%+ holder of Cocrystal Pharma Inc.
Sign up freeLoading...